Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stemedica To Meet FDA Regarding Pre-IND
Stemedica Cell Technologies has requested a pre-Investigational New Drug (IND) meeting with the FDA. The purpose is to discuss a proposed IND to use Stemedica’s proprietary line of
Stemedica Cell Technologies has requested a pre-Investigational New Drug (IND) meeting with the FDA. The purpose is to discuss a proposed IND to use Stemedica’s proprietary line of
The FDA has approved Sabril (vigabatrin) oral solution to treat infantile spasms in children aged 1 month to 2 years. Sabril (vigabatrin) Tablets have been approved for adult
Lonza has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of $3.55 per Restricted Voting Share. Patheon expects
Revenue growth on a constant currency basis was 10% after adjusting for a $145 million negative foreign currency translation. This quarter contained 14 weeks, one more week than
Qualitest Pharmaceuticals has issued a voluntary nationwide recall of Accusure Insulin Syringes (1/2 cc – 31 G – Short Needle) with lot number: 6JCB1 (Expiration 10/2011) – NDC
Tibotec has announced a new treatment option for children living with HIV. Two new lower dose 75mg and 150mg formulations of Prezista (darunavir) twice daily, co-administered with low-dose
Epocal has received US Food and Drug Administration’s (FDA) clearance to market its new glucose test on the epoc Blood Analysis System. Imants Lauks, president and founder of
MediciNova and Avigen have entered into a definitive merger agreement pursuant to which MediciNova’s wholly-owned subsidiary will merge with and into Avigen. Reportedly, completion of the transaction will
IntelGenx has reported that the New Drug Application (NDA) filing for the antidepressant – CPI-300 has been accepted by the FDA for standard review. In connection with the
Astellas has announced that the groundbreaking ceremony for Fermentation Technology Research Building in the Toyama Plant of its subsidiary, Astellas Toyama, will be held on August 24, 2009.